These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advanced glycation end product free adducts are cleared by dialysis. Agalou S; Ahmed N; Thornalley PJ; Dawnay A Ann N Y Acad Sci; 2005 Jun; 1043():734-9. PubMed ID: 16037300 [TBL] [Abstract][Full Text] [Related]
4. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296 [TBL] [Abstract][Full Text] [Related]
5. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352 [TBL] [Abstract][Full Text] [Related]
6. Measurement of protein glycation, glycated peptides, and glycation free adducts. Thornalley PJ Perit Dial Int; 2005; 25(6):522-33. PubMed ID: 16419322 [TBL] [Abstract][Full Text] [Related]
7. Highlights and hotspots of protein glycation in end-stage renal disease. Thornalley PJ; Rabbani N Semin Dial; 2009; 22(4):400-4. PubMed ID: 19708990 [TBL] [Abstract][Full Text] [Related]
8. Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients. Piroddi M; Depunzio I; Calabrese V; Mancuso C; Aisa CM; Binaglia L; Minelli A; Butterfield AD; Galli F Amino Acids; 2007; 32(4):573-92. PubMed ID: 17356806 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis. Lapolla A; Flamini R; Lupo A; Aricò NC; Rugiu C; Reitano R; Tubaro M; Ragazzi E; Seraglia R; Traldi P Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242 [TBL] [Abstract][Full Text] [Related]
10. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of markers of protein damage by glycation, oxidation, and nitration in peritoneal dialysis. Rabbani N; Thornalley PJ Perit Dial Int; 2009 Feb; 29 Suppl 2():S51-6. PubMed ID: 19270232 [TBL] [Abstract][Full Text] [Related]
12. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168 [TBL] [Abstract][Full Text] [Related]
13. Carbonyl stress in chronic renal failure: the effect of haemodialysis. Dursun E; Dursun B; Süleymanlar G; Ozben T Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036 [TBL] [Abstract][Full Text] [Related]
14. Protein oxidative stress in dialysis patients. Doñate T; Herreros A; Martinez E; Martinez J; Andrés E; Cabezas A; Ortiz A; de Prado A; Pou JM; Pamplona R; Portero Otin M; Bellmunt MJ Adv Perit Dial; 2002; 18():15-7. PubMed ID: 12402579 [TBL] [Abstract][Full Text] [Related]
15. Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Ahmed N; Mirshekar-Syahkal B; Kennish L; Karachalias N; Babaei-Jadidi R; Thornalley PJ Mol Nutr Food Res; 2005 Jul; 49(7):691-9. PubMed ID: 15945118 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591 [TBL] [Abstract][Full Text] [Related]
17. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis. Kawanishi H; Moriishi M; Tsuchiya S Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589 [TBL] [Abstract][Full Text] [Related]
18. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123 [TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
20. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]